Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
| CEO | Balkrishan Gill Ph.d (Simba) |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 75 |
| Date Founded | 2015 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $11.3M |
| Net Income | -$114,527,000 |
| Tax Rate | -0.0% |
| Total Assets | $64,441,000 |
| Ticker | EVLO |
Evelo Biosciences received early financing of $35.0M on 2015-11-04.
| Series | Round size | Date |
|---|---|---|
| Series A | $35M | 11/2015 |
| Series B | $50M | 07/2017 |
| Series C | $81.5M | 02/2018 |
| Series Unknown | $47.5M | 04/2018 |
| Post Ipo Equity | $67.5M | 01/2021 |
| Investors | Security type |
|---|---|
| Flagship Pioneering Inc | Series A |
| Celgene Corporation | Series B |
| GV | Series B |
| Mayo Clinic Ventures | Series B |
| Flagship Pioneering Inc | Series B |
| Alexandria Venture Investments | Series B |
| Dementia Discovery Fund | Series Unknown |
Evelo Biosciences's top competitor, Epizyme, earned an annual revenue of $37.4M.
Evelo Biosciences's smallest competitor is Synlogic with revenue of $8.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Neon Therapeutics | - | $1.6M | 50 | - |
| Aduro BioTech | - | $17.3M | 175 | - |
| Synlogic | - | $8,000 | 74 | - |
| Infinity Pharmaceuticals | - | $2.6M | 100 | - |
| CRISPR Therapeutics | - | $37.3M | 304 | - |
| Epizyme | - | $37.4M | 124 | - |
Zippia gives an in-depth look into the details of Evelo Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Evelo Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Evelo Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Evelo Biosciences. The data presented on this page does not represent the view of Evelo Biosciences and its employees or that of Zippia.
Evelo Biosciences may also be known as or be related to EVELO BIOSCIENCES, INC., Evelo Biosciences, Evelo Biosciences Inc, Evelo Biosciences, Inc. and Evelo Therapeutics, Inc.